Caris Life Sciences CAI Income Statement (2023-2026)

NASDAQ CAI
$21.76 -1.28 (-5.56%)
As of: Nov 16, 2026 · 11:29 AM EST
Reported Financials

Caris Life Sciences Quarterly Income Statement

Periods 11 quarters
Latest Sep 2026

Caris Life Sciences reported revenue of $275.36M and net income of $15.25M for the quarter ended Sep 2026, up 27.0% year over year. This income statement covers 11 quarters of results from Dec 2023 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Income StatementIncome Statement Dec2023 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Revenue & cost
Revenue 100.05M101.62M129.92M120.92M181.40M216.83M292.89M216.17M263.71M275.36M
Cost of RevenueCost of Rev 62.50M57.21M59.21M63.85M67.71M69.33M71.97M74.83M84.12M93.07M
Gross Profit 37.55M44.41M70.70M57.06M113.69M147.51M220.91M141.35M179.60M182.29M
Operating items
Research & DevelopmentR&D 24.79M27.64M27.11M23.07M25.05M21.62M31.85M31.32M32.36M33.84M
Selling, General & AdministrativeSG&A 41.07M40.85M43.11M52.12M64.37M51.97M56.51M59.71M66.55M69.28M
Other Operating ExpensesOther Opex 38.71M36.76M37.53M39.83M42.26M41.27M44.15M45.04M53.76M59.85M
Operating ExpensesOpex 167.06M162.46M166.96M178.87M199.39M184.19M204.48M210.89M236.79M256.04M
Operating IncomeOp. Inc -67.01M-60.84M-37.05M-57.95M-17.99M32.64M88.41M5.28M26.93M19.32M
Non-operating items
Non Operating Interest Expenses 13.67M13.80M13.26M12.78M19.21M13.51M11.36M12.81M9.23M9.25M
Gains (Losses) on Sale of Assets & InvestmentsGains on Sales -32.33M-17.87M-2.08M52.29M-0.26M-0.15M
Interest & Investment IncomeInt & Inv Inc 2.64M1.74M0.97M0.50M1.62M7.36M7.02M6.83M6.82M6.33M
Other Non Operating IncomeOther Non Op Inc. -0.14M0.04M-0.03M-0.02M-18.34M-0.09M-2.11M0.05M-25.13M0.48M
Non Operating IncomeNon Op. Inc. 0.83M-6.89M0.10M-44.63M-53.80M-8.32M-6.45M-5.93M-27.54M-2.44M
Net income details
EBIT -67.01M-60.84M-37.05M-57.95M-17.99M32.64M88.41M5.28M26.93M19.32M
EBT -66.19M-67.73M-36.95M-102.58M-71.79M24.33M81.96M-0.64M-0.61M16.87M
Tax ProvisionsTaxes -0.13M0.02M1.62M
Income After Tax -66.19M-67.73M-36.95M-102.58M-71.79M24.33M81.96M-0.51M-0.64M15.25M
Income from Continuing OperationsIncome (Continuing) -66.19M-67.73M-36.95M-102.58M-71.79M24.33M81.96M-0.51M-0.64M15.25M
Consolidated Net IncomeConsol Net Inc. -66.09M-67.73M-36.95M-102.55M-71.37M24.33M81.96M-0.55M-1.00M15.25M
Net Income Attributable to Noncontrolling InterestsNCI Net Income -67.85M24.40M14.62M
Income towards Parent CompanyParent Net Inc -66.19M-67.73M-36.95M-102.58M-71.79M24.33M81.96M-0.51M-0.64M15.25M
Preferred Dividend PaymentsPref Dividends 23.59M24.66M25.00M24.46M384.44M
Net Income towards Common StockholdersNet Income -89.78M-92.39M-61.95M-127.04M-517.20M24.33M81.96M-0.51M-0.64M15.25M
Additional items
EPS (Basic) -2.54-2.59-1.75-3.57-7.970.090.490.000.000.05
EPS (Diluted) -2.54-2.59-1.75-3.57-7.970.080.490.000.000.05
Shares Outstanding 34.94M35.37M35.64M35.50M35.62M64.92M282.10M167.21M282.56M282.89M283.89M
Shares Outstanding (Diluted)Shares Outstanding (Dil.) 34.94M35.37M35.64M35.50M35.62M64.92M297.21M167.21M282.56M282.89M295.14M
Shares Outstanding (Entity)Shares Outstanding (Entity.) 35.30M35.42M35.82M36.50M35.24M64.92M282.10M167.21M282.65M282.58M286.72M
EBITDA -53.68M-48.52M-26.07M-48.96M-3.83M40.01M93.31M13.01M33.72M26.23M
Interest ExpensesInt Expense 13.67M13.80M13.26M12.78M19.21M13.51M11.36M12.81M9.23M9.25M
Tax Rate 9.62%

Caris Life Sciences Income Statement API

Pull Caris Life Sciences's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=CAI&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEY